Orally administering parathyroid hormone and calcitonin

Details for Australian Patent Application No. 2006225157 (hide)

Owner Novartis AG

Inventors Bateman, Simon David; McLeod, James F.; Azria, Moise; Ault, Joseph M.

Agent Davies Collison Cave

Pub. Number AU-B-2006225157

Parent 2002344371

Filing date 29 September 2006

Wipo publication date 19 October 2006

Acceptance publication date 23 April 2009

International Classifications

A61K 38/29 (2006.01) Medicinal preparations containing peptides - Parathyroid hormone (parathormone)

A61K 35/60 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/23 (2006.01) Medicinal preparations containing peptides - Calcitonins

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

19 October 2006 Application Open to Public Inspection

  Published as AU-B-2006225157

19 October 2006 Complete Application Filed

23 April 2009 Application Accepted

  Published as AU-B-2006225157

20 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006225158-Mutant endonuclease

2006225155-A fish handling device